Skip to main content

Peer Review reports

From: No increased risk of glucose metabolism disorders in adults with growth hormone deficiency undergoing long-term treatment with biosimilar somatropin (Omnitrope®): data from an observational, longitudinal study

Original Submission
31 May 2019 Submitted Original manuscript
4 Aug 2019 Reviewed Reviewer Report - So Nagai
18 Aug 2019 Reviewed Reviewer Report - Luis Miguel Roman-Pintos
9 Oct 2019 Author responded Author comments - Paolo Beck-Peccoz
Resubmission - Version 2
9 Oct 2019 Submitted Manuscript version 2
20 Oct 2019 Reviewed Reviewer Report - So Nagai
26 Oct 2019 Reviewed Reviewer Report - Luis Miguel Roman-Pintos
11 Nov 2019 Author responded Author comments - Paolo Beck-Peccoz
Resubmission - Version 3
11 Nov 2019 Submitted Manuscript version 3
19 Nov 2019 Author responded Author comments - Paolo Beck-Peccoz
Resubmission - Version 4
19 Nov 2019 Submitted Manuscript version 4
Publishing
29 Nov 2019 Editorially accepted
11 Dec 2019 Article published 10.1186/s12902-019-0464-2

You can find further information about peer review here.

Back to article page